Reporting owner · Q3 2026 · CIK 1740963

Chopra Daveen: insider trades.

Chopra Daveen reported 4 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 2 sales ($2.9M), across 1 company.

Transactions
4
Purchases (P)
0
Sales (S)
2
Companies
1
Name as filed
Chopra Daveen

Companies

CompanyRelationshipTransactions
Edwards Lifesciences Corp (EW)Officer · CVP, TMTT, Surgical & IHFM4

Transactions

4 non-derivative rows. Shares and prices as filed.
DateCompanyCodeSharesPriceOwned afterFiling
2026-09-11Edwards Lifesciences CorpF398$86.7743,926Form 4
2026-08-26Edwards Lifesciences CorpM31,800$72.6876,124Form 4
2026-08-26Edwards Lifesciences CorpS30,646$90.9944,324Form 4
2026-08-26Edwards Lifesciences CorpS1,154$91.7674,970Form 4

Questions

What stock did Chopra Daveen buy or sell?

Chopra Daveen reported 4 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 2 sales ($2.9M), across 1 company.

Is Chopra Daveen the same person as other filers with this name?

This page covers SEC CIK 1740963 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.

Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.

Plain-text version for agents and LLMs: /insiders/chopra-daveen-1740963.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.